Q4 sales was SEK 45m (-6% vs. SEB at SEK 48m) corresponding to 24% y/y growth at constant exchange rates (SEBe: 28%). Gross margin continued to be strong and with opex in line with our forecast, Q4 adj. EBIT was SEK -9m (SEB at SEK -7m). FactSet cons had expected SEK 47m sales and SEK -10.6m EBIT. We expect LSD, potentially MSD, negative revisions to 2026E sales on this report, likely lower revisions to 2028E sales.
LÄS MER
